Down's syndrome results from full or partial trisomy of chromosome 21. However, the consequences of the underlying gene-dosage imbalance on adult tissues remain poorly understood. Here we show that in Ts65Dn mice, which are trisomic for 132 genes homologous to genes on human chromosome 21, triplication of Usp16 reduces the self-renewal of haematopoietic stem cells and the expansion of mammary epithelial cells, neural progenitors and fibroblasts. In addition, Usp16 is associated with decreased ubiquitination of Cdkn2a and accelerated senescence in Ts65Dn fibroblasts. Usp16 can remove ubiquitin from histone H2A on lysine 119, a critical mark for the maintenance of multiple somatic tissues. Downregulation of Usp16, either by mutation of a single normal Usp16 allele or by short interfering RNAs, largely rescues all of these defects. Furthermore, in human tissues overexpression of USP16 reduces the expansion of normal fibroblasts and postnatal neural progenitors, whereas downregulation of USP16 partially rescues the proliferation defects of Down's syndrome fibroblasts. Taken together, these results suggest that USP16 has an important role in antagonizing the self-renewal and/or senescence pathways in Down's syndrome and could serve as an attractive target to ameliorate some of the associated pathologies.
Down's syndrome results from full or partial trisomy of chromosome 21. However, the consequences of the underlying gene-dosage imbalance on adult tissues remain poorly understood. Here we show that in Ts65Dn mice, which are trisomic for 132 genes homologous to genes on human chromosome 21, triplication of Usp16 reduces the self-renewal of haematopoietic stem cells and the expansion of mammary epithelial cells, neural progenitors and fibroblasts. In addition, Usp16 is associated with decreased ubiquitination of Cdkn2a and accelerated senescence in Ts65Dn fibroblasts. Usp16 can remove ubiquitin from histone H2A on lysine 119, a critical mark for the maintenance of multiple somatic tissues. Downregulation of Usp16, either by mutation of a single normal Usp16 allele or by short interfering RNAs, largely rescues all of these defects. Furthermore, in human tissues overexpression of USP16 reduces the expansion of normal fibroblasts and postnatal neural progenitors, whereas downregulation of USP16 partially rescues the proliferation defects of Down's syndrome fibroblasts. Taken together, these results suggest that USP16 has an important role in antagonizing the self-renewal and/or senescence pathways in Down's syndrome and could serve as an attractive target to ameliorate some of the associated pathologies.
Down's syndrome is a complex clinical syndrome associated with multiple pathological conditions, including deficits in motor skills and learning 1, 2 . It has also been associated with early onset and higher incidence of ageing-related phenomena such as Alzheimer's disease 3, 4 . Recently, it has been proposed that the ageing process is correlated with an impaired or exhausted ability of stem cells to self-renew 5 , raising the possibility that stem-cell defects have a role in Down's syndrome.
To gain insights into the molecular mechanisms underlying abnormalities of tissue homeostasis in Down's syndrome, we investigated haematopoietic stem cells in two Down's syndrome mouse models, Ts65Dn and Ts1Cje (Fig. 1a) . Ts65Dn mice have a third copy of approximately two-thirds of the murine genes homologous to genes on human chromosome 21 and recapitulate several traits of the human disease, including learning and memory deficits 6 . Ts1Cje mice present only 79 of the 132 trisomic genes of Ts65Dn mice (Fig. 1a) 1 and certain defects, such as neurologic impairment, are less severe in these mice 7, 8 . One of the genes uniquely triplicated in Ts65Dn is Usp16, a deubiquitination enzyme involved in chromatin remodelling and cell cycle progression 9 . Our studies implicated Usp16 as a major factor causing expansion defects and senescence in multiple somatic tissues of Ts65Dn mice.
Ts65Dn, but not Ts1Cje, mice have defective HSCs
Consistent with previous observations 10 , transplantation of 5 3 10 5 CD45.2 1 Ts65Dn cells into CD45.1 1 C57BL/6 lethally irradiated mice resulted in lower haematopoietic chimaerism in recipient mice compared to transplantation of control bone marrow cells (Extended Data Fig. 1a ). To determine the trisomic genes responsible for the impaired engraftment potential of the Ts65Dn bone marrow cells, we investigated the frequency and properties of haematopoietic stem cells (HSCs) 11, 12 , was reduced by more than threefold in Ts65Dn mice, but not in Ts1Cje mice (Fig. 1b, c and Extended Data Fig. 1b) .
A 50% reduction in in vitro colony formation by single CD34
2

CD150
1 CD48 2 KLS cells compared to controls further suggested an impairment of Ts65Dn HSCs (Fig. 1d ) 12 . To assess definitively the function of HSCs in Down's syndrome, we performed serial dilution bone marrow transplantations with euploid, Ts65Dn and Ts1Cje cells. Wild-type and Ts1Cje bone marrow cells reconstituted the bone marrow of lethally irradiated recipient mice with a similar HSC calculated frequency (1 out of 80,338 and 1 out of 103,553, respectively). However, there was a threefold reduction in the frequency of Ts65Dn stem cells (1 out of 307,431; P 5 0.0294) (Fig. 1e and Extended Data Fig. 1c) . Furthermore, multi-lineage engraftment of Ts65Dn bone marrow cells was not observed in secondary transplants after 3 months ( Fig. 1f and Extended Data Fig. 1d ), confirming a severe impairment in the self-renewal ability of Ts65Dn haematopoietic cells.
Usp16 contributes to HSC defects in mice
Usp16 is one of the genes uniquely triplicated in Ts65Dn mice but not in Ts1Cje mice. Previous studies have reported that Usp16 can remove ubiquitin moieties from histone H2A, opposing the ubiquitination function of the Polycomb repressive complex 1 (PRC1) 9 . As Bmi1, a crucial member of the PRC1 complex, is essential for the self-renewal of stem cells in multiple tissues [13] [14] [15] [16] , we postulated that an extra copy of Usp16, an antagonist of PRC1, could impair the self-renewal ability of stem cells in Ts65Dn mice. Consistent with the presence of three alleles, Usp16 messenger RNA was expressed 1.5-fold higher in Ts65Dn HSCs compared to control HSCs (Fig. 1g) . Moreover, immunofluorescence studies showed a twofold reduction in the number of ubiquitinated chromatin foci in Ts65Dn CD34 2 CD150 1 CD48 2 KLS cells (Fig. 1h, i ). Both immunofluorescence and western blots analyses also demonstrated a reduction in the levels of H2AK119 ubiquitination in Ts65Dn mouse embryonic fibroblasts (MEFs) (Extended Data Fig. 2 ).
To determine whether increased levels of Usp16 contribute to abnormalities of Ts65Dn HSCs, we generated lentiviral constructs encoding green fluorescent protein (GFP) and short interfering RNAs (shRNAs) directed against a scrambled sequence (shC) or Usp16 (shUsp16 no. 1 and shUsp16 no. 2). These hairpins reduce Usp16 expression to 40-50%, leading to a final expression level similar to the one observed in control animals (Extended Data Fig. 3a) . In total, 40% of single CD34 2 CD150
1
CD48
2 KLS Ts65Dn bone marrow cells infected with the shUsp16 lentivirus formed in vitro colonies in MethoCult, compared to 20% of the shC-infected cells (Fig. 1j) (P , 0.04).
To assess the effect of Usp16 in vivo, Ts65Dn KLS cells were infected with shUsp16 or shC lentivirus and then injected into lethally irradiated C57BL/6 recipient mice. shUsp16-infected cells, but not shC-infected cells, significantly engrafted in recipient mice ( Fig. 1k and Extended Data Fig. 3b ). Unlike Ts65Dn bone marrow cells treated with a control lentivirus, the cells transduced with the shUsp16 lentivirus could also give rise to multipotent differentiation upon serial transplantation ( Fig. 1l and Extended Data Fig. 3c ). These results demonstrate that the self-renewal defect of Ts65Dn HSCs can be substantially rescued by downregulation of Usp16 alone.
Role of Usp16 in Ts65Dn neural progenitor defects
Usp16 is expressed in a key site of adult neurogenesis, the brain subventricular zone (SVZ) (Extended Data Fig. 4a ). Because Bmi1 is known to be critical for the maintenance of neural progenitors 15, 16 , we proposed that an extra copy of the PRC1 antagonist Usp16 could have a role in regulating also their expansion in Ts65Dn mice. To test this hypothesis, the SVZ was micro-dissected from 8-week-old mice brains, and Lin
2 ) were enriched by flow cytometry and assayed for neurosphere formation during serial passaging in vitro. As reported previously, in vitro sphere formation by Ts65Dn neural progenitors was impaired 7, 8, 17 . By the fourth passage, 1 out of 21 wild-type cells formed neurospheres, whereas only 1 out of 958 Ts65Dn Lin 2 cells could do so (P , 0.0001) ( Fig. 2a  and Extended Data Fig. 4b ). To define the role of an extra copy of Usp16 in neural progenitor expansion, Ts65Dn mice were bred with mice in which one of the normal Usp16 alleles was mutated (Usp16 het ). The offspring had a normal diploid dosage of Usp16, but retained three copies of the other genes present in the Ts65Dn parental strain (Ts65Dn/Usp16 het mice). Notably, Ts65Dn/Usp16 het neural progenitor cells maintained a normal frequency of neurosphere-initiating cells (Nsp-ICs) during serial passage (P , 0.0001) (Fig. 2a, b) .
After four passages, expression of Sox2 (a known neural progenitor cell marker) 18 19, 20 , which are enriched for neural progenitor cells. These cells express high levels of nestin and Sox2 and retain the ability to expand in vitro upon serial passaging (Extended Data Fig. 5 ARTICLE RESEARCH ( Fig. 2d and Extended Data Fig. 4c ). Moreover, Ts65Dn, but not Ts65Dn/Usp16 het , neural progenitors showed a significant decrease in formation of secondary neurospheres (P , 0.0001) (Fig. 2e) . Taken together, these data show that Ts65Dn mice have a defect in the expansion of neural progenitors that can be partially rescued by eliminating an extra allele of Usp16.
Role of Usp16 in mammary epithelium of Ts65Dn mice
Loss of Bmi1 results in severe mammary epithelium growth defects 14 . We therefore wanted to know whether the extra copy of Usp16 in Ts65Dn mice might also affect the expansion of mammary epithelial cells. Like HSCs, Usp16 mRNA expression was increased approximately 1.5-fold in Ts65Dn CD49f 1 CD24 medium Lineage 2 cells (which are enriched for mammary repopulating units (MRUs) 21, 22 ) compared to control cells (Extended Data Fig. 6a ). Moreover, several Hox genes, usually repressed by PRC1, were highly expressed in Ts65Dn cells (Extended Data Fig. 6b ). Immuno-phenotypical analysis of the breast tissue from Ts65Dn mice revealed a significant reduction of the overall number of CD31 2 CD45 2 Ter119 2 (Lineage 2 ) cells ( Fig. 3a and Extended Data Fig. 6c ). Cytokeratin staining showed that compared to wild-type or Ts1Cje mice, Ts65Dn mice have an increased number of cells that co-express luminal cell cytokeratin-8 and basal cell cytokeratin-14 ( Fig. 3b and Extended Data Fig. 6d ), suggesting abnormalities in the development of the mammary epithelium.
To functionally test CD49f 1 CD24 med Lin 2 cells, a population enriched with regeneration potential 21, 22 , we performed three-dimensional in vitro colony assays. Ts65Dn, but not Ts1Cje, cultures showed a reduced number of colonies (Fig. 3c) . Moreover, in vivo mammary transplantation assays with Lin 2 cells showed a significant decrease in repopulating ability of Ts65Dn Lin 2 cells compared to wild type or Ts65Dn/ Usp16 het Lin 2 cells (Fig. 3d ). As in HSCs and neural progenitors, lentiviral downregulation of Usp16 in Ts65Dn Lin 2 cells partially rescued mammary epithelium defects. There was a twofold increase in the calculated frequency of MRUs in shUsp16-infected Lin 2 Ts65Dn cells, and the derived outgrowths were larger compared to cells infected with control shRNA (Extended Data Fig. 6e ). However, we were unable to generate mammary glands in secondary transplants of the Ts65Dn/Usp16 het mammary epithelial cells, suggesting that other genes may affect the proliferation of these cells in Ts65Dn mice.
Modulation of Ink4a/Arf by Usp16 in Ts65Dn cells
One of the best-characterized Bmi1/PRC1 target loci is Cdkn2a 23 , which encodes two distinct tumour suppressors, p16
Ink4a and p19
Arf .
Expression of p16
Ink4a and p19 Arf normally increases with age in both rodent and human tissues and is involved in senescence-induced loss of proliferation [24] [25] [26] . To determine whether Usp16 trisomy affects proliferation and senescence, we used MEFs and terminal-tip fibroblasts (TTFs). Ts65Dn, but not Ts65Dn/Usp16 het , TTFs showed a marked proliferation deficit and high levels of senescence as shown by senescence-associated b-galactosidase staining and by p16 Ink4a expression (Fig. 4a, b) . These defects were partially rescued by a shRNA targeting Cdkn2a (Fig. 4b and Extended Data Fig. 7a-c) . Ts65Dn MEF cultures showed high levels of senescence and a rapid increase of p16 Ink4a and p19 Arf expression levels upon passaging ( Fig. 4c and Extended Data Fig. 7d) 
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of Usp16 with two different hairpins decreased p16
Arf expression (Fig. 4d) . Western blots showed decreased levels of H2AK119 ubiquitination in Ts65Dn MEFs (Extended Data Fig. 2) and chromatin immunoprecipitation analyses demonstrated a decrease in H2AK119 ubiquitin on the Ink4a/Arf locus in Ts65Dn MEFs (Fig. 4e) . These results strongly suggest that trisomy of Usp16 contributes to the cellular defects observed in Ts65Dn mice through increased removal of ubiquitin moieties from H2A, with an impact on the Cdkn2a site. However, mutational analyses of the deubiquitinase domains would be required to confirm this model.
Potential role USP16 in human Down's syndrome
As reported previously 27, 28 , fibroblasts derived from Down's syndrome patients showed a strong proliferation defect. Moreover, they appear to senesce prematurely (Fig. 5a ). Gain-of-function experiments were performed using normal fibroblasts to determine whether USP16 overexpression might contribute to the proliferation defects. Transduction of normal foreskin fibroblasts with a vector overexpressing USP16 slowed their proliferation (Fig. 5b and Extended Data Fig. 8a ). Conversely, shRNA-mediated downregulation of USP16 or overexpression of BMI1 resulted in increased proliferation capacity of Down's syndrome fibroblasts (Fig. 5c and Extended Data Fig. 8b, c) . ARTICLE RESEARCH (Fig. 5d and Extended Data Fig. 8d) . These experiments suggest a role for the third copy of USP16 in the pathologies associated with Down's syndrome.
Discussion
Our data show that the change in self-renewal capacity of HSCs and neural progenitors, as well as the proliferation defects of mammary epithelial cells and fibroblasts in Ts65Dn mice, is linked in part to trisomy of Usp16, a negative modifier of the PRC1 activity 9 . As Bmi1, a component of PRC1, is known to regulate senescence and self-renewal of multiple somatic stem cells, this suggests that some of the pathologies associated with Down's syndrome may result from a stem-cell imbalance secondary to overexpression of Usp16. Clearly, other genes also have a role in traits associated with Down's syndrome patients, such as craniofacial abnormalities and perhaps the increased incidence of leukaemia and the decreased incidence of solid tumours (Extended Data Fig. 9) 2,29 , and there are probably differences between humans with Down's syndrome and Ts65Dn mice. Nonetheless, the defects of human fibroblasts mirror those seen in the mouse models, and the effect of overexpression of Usp16 in human neural progenitors suggest that this gene has a similar function in human Down's syndrome and in Ts65Dn mice. Although we cannot unequivocally state that the HSCs are reduced in Down's syndrome patients, in two children we examined they were not increased as they might be in the liver of some human Down's syndrome fetuses (Extended Data Fig. 9 ) 30 .
In conclusion, our data demonstrate a new axis of regulation of tissue homeostasis in multiple tissues. We believe that our study has broad implications for understanding one of the most common genetic abnormalities in humans, Down's syndrome, and that targeting the USP16 pathway may ameliorate some of the associated pathologies.
METHODS SUMMARY
Mice. Nonobese diabetic/severe combined immunodeficiency (NOD/SCID), Ts65Dn, Ts1Cje and euploid littermate mice were purchased from Jackson Laboratories. 6 s.e.m. as error bars, unless otherwise specified. P values were calculated using two-tailed t-test analyses. For limiting dilution analyses, ELDA software or L-Calc were used to test inequality between multiple groups. Expected frequencies are reported, as well as the 95% confidence intervals (lower and upper values are indicated). *P , 0.05, **P , 0.01, ***P ,0.001
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METHODS
Statistical analyses. In all the graphs, bars show average as central values and 6 s.e.m. as error bars, unless otherwise specified. P values were calculated using two-tailed t-test analyses. For limiting dilution analyses, ELDA software or L-Calc were used to test inequality between multiple groups. Expected frequencies are reported, as well as the 95% confidence intervals (lower and upper values are indicated). *P , 0.05, **P , 0.01, ***P ,0.001 Mice. Ts65Dn, Ts1Cje and euploid littermates mice (mixed background B6EiC3SnF1/J) were purchased from Jackson Laboratories. Mice were genotyped by real-time PCR or by traditional PCR as described previously 31 or according to animal's provider. Control littermates were used as wild-type mice. These mice are heterozygous for B6 and C3H alleles at all loci in their genome. C57BL/6 CD45.1 mice, used for bone marrow transplantation experiments, were kindly provided by I. Weissman. Usp16 het mice (FVB/N-
/Mmjax) were ordered from Mutant Mouse Regional Resource Centers (MMRRC). Weaningage nonobese diabetic/severe combined immunodeficiency (NOD/SCID) female mice were purchased by Jackson Laboratories. Mice were housed in accordance with the guidelines of Institutional Animal Care Use Committee. Bone marrow and peripheral blood analyses. Isolation and analyses of bone marrow cells were performed as described previously 12 . In brief, bone marrow cells were isolated by crushing long bones and hips with mortal and pestle in calcium-and magnesium-free Hank's balanced salt solution (HBSS) with 2% heat-inactivated bovine serum. The cells were drawn by passing through a 25G needle several times, treated with ammonium chloride potassium (ACK) for 1 min and filtered with a 40-mm nylon mesh. Before sorting, progenitor cells were enriched through magnetic isolation with mouse lineage cell depletion kit (Miltenyi Biotec) using an autoMACS pro Separator. Markers used for identification of lineage cells were CD3, CD5, CD8, Gr-1, B220 and Ter119.
For peripheral blood analysis, red blood cells were lysed with hypotonic buffer, and nucleated cells were stained with antibodies against CD45.1, CD45.2, Ter119, Gr-1, Mac-1, CD3 and B220.
Details of antibodies used for analyses and sorting of hematopoietic cells: c-Kit APC780, CD45R (B220) phycoerythrin (PE)-Cy5, CD45R (B220) PE, Ly6G (Gr-1) APC, CD8a PE-Cy5, CD3e Cy5, CD3e PE, CD135 (Flt3) APC, CD34 FITC, CD45.1 PE, CD45.2 FITC (eBioscience); CD150 PE, CD48 APC, Sca1 PacBlue, Ter119 PacBlue, Ter119 PE-Cy5, CD5 PE-Cy5, CD11b (Mac1) APC (Biolegend).
Cells were gated on the basis of forward-and side-scatter profiles, and live/dead discrimination was obtained with 7-amino-actinomycin D (7-AAD) or DAPI. Analyses and sorting was performed using a FACS Aria II (BD Biosciences). Data were also analysed with FlowJo software. Bone marrow transplants. Recipient C57BL/6 CD45.1 mice (8-12 weeks old) were lethally irradiated (1,140 rad), with two doses of radiations delivered 3 h apart. Bone marrow single-cell suspensions were obtained from long bones and hips of Ts65Dn, Ts1Cje and wild-type mice (8-12 weeks old) and treated for 1 min with ACK for red-cell lysis. Only donor animals with a matching haplotype for the major histocompatibility antigens were used (H-2K b/b ) 10 . Recipient mice were competitively reconstituted by retro-orbital venous sinus injection with three different doses (5 3 10 5 cells, 1.5 3 10 5 cells, 0.5 3 10 5 cells) of whole bone marrow cells from donor mice and a radioprotective dose of 3 3 10 5 bone marrow cells from non-irradiated C57BL/6/Ka-CD45.1 mice. Five mice were used for each group. Mice were analysed monthly for reconstitution of peripheral blood.
For secondary transplants, 5 3 10 6 bone marrow cells were collected at least 4 months after primary transplants from engrafted recipients, and injected in lethally irradiated C57BL/6 CD45.1 mice. Reconstitution was measured in peripheral blood at the indicated time points.
For transplantation of lentivirus-infected Ts65Dn marrow cells, KLS cells were isolated and sorted from 8-12-week-old Ts65Dn H-2K b/b mice. Sorted KLS were incubated overnight with the indicated lentivirus (multiplicity of infection (m.o.i.) 5 200). The morning after, KLS were washed, mixed with a radioprotective dose of 3 3 10 5 bone marrow cells from non-irradiated C57BL/6/Ka-CD45.1 mice, and injected in lethally irradiated mice. In parallel, 48 h after infection we verified by FACS the level of GFP expression in infected cells, to make sure that the level of lentiviral integration would be similar between multiple samples.
For all transplantation experiments, we considered as repopulated by donor cells the mice that had more than 1% donor-derived (CD45.2 1 ) cells in both lymphoid (CD3 1 and B220 1 ) and myeloid (Gr-1 1 and Mac-1 1 ) subpopulations. Frequency of long-term reconstituting cells from limiting dilution experiments was calculated using ELDA software 32 . All the transplants were repeated at least twice. In vitro colony formation of HSCs. For MethoCult cultures, we double-sorted single HSCs into U-bottom 96-well plates containing 100 ml of MethoCult GF M3434 media (Stemcell Technologies) as described previously 12 . Positive colonies were scored after 7 days of culture.
Neurosphere assays. Wild-type, Ts65Dn, Ts65Dn/Usp16 het and Usp16 het mice were euthanized by CO 2 , decapitated, and their brains immediately removed. The SVZ was micro-dissected and stored in ice-cold PBS for further processing. The tissue was digested using TryPLE express (Invitrogen) and DNase I (250 U ml 21 ) at 37 uC for 10 min followed by trituration using a fire-polished pipette. Digested tissue was washed in ice-cold PBS without calcium and magnesium, filtered through a 40-mm filter and re-suspended in neurospheres growth media that is, Neurobasal-A (Invitrogen) and Dulbecco's modified Eagle's medium (DMEM) F/12 (1:1) supplemented with 2% B27-A (Invitrogen), 1% N2 (Invitrogen), mouse recombinant epidermal growth factor (EGF; 20 ng ml
21
) and basic fibroblast growth factor (bFGF; 20 ng ml 21 ) (Shenandoah Biotechnology) and 2 mg ml 21 heparin (Sigma). Lineage cells were depleted using mouse CD45, CD31, CD34 and Ter119 microbeads (Miltenyi Biotec) and the negative fraction collected. For FACS analysis the cells were stained with anti-CD15-fluorescein isothiocyanate (FITC) (MMA; BD), anti-prominin1-APC (eBiosciences) and biotinylated EGF complexed with PE-Cy7-streptavidin (2 mg ml 21 ; Invitrogen). For limiting dilution analysis, cells were directly plated in 96 wells in limiting dilution down to one cell per well. Each plating dose was done in 24 wells and the number of wells with neurospheres was counted after 10 days. For serial passaging, neurospheres from each passage were collected and re-plated either as 100 cells per well in a 48-well dish or in a similar limiting dilution fashion as described above.
Micro-dissected mouse SVZ was dissociated as described above and FACSsorted into 2 cells. In total, 10,000 cells were sorted for each population and concentrated by centrifugation. Cells were collected on a glass slide by cytospin and air dried before methanol fixation. Fixed cells were blocked using 5% normal goat serum and incubated in rabbit antiSox2 antibody (ab97959, Abcam) and mouse anti-nestin antibody (2Q178, Abcam), followed by secondary anti-mouse Alexa 594 and anti-rabbit Alexa 488, respectively. Fluorescence was visualized using standard epifluorescence microscopy. Six random fields were imaged and data represented as ratio of Sox2-or nestinpositive cells per DAPI-positive cells in the same field. Mouse breast analyses. Mammary glands were dissected from either wild-type, Ts65Dn or Ts1Cje mice and analysed as described previously 21 . In brief, the glands were digested in collagenase/hyaluronidase followed by ACK lysis, trypsin and DNAase/dispase. The cells were then stained with the following antibodies: CD49f APC, CD24 PE-Cy7, CD45 PacBlue, Ter119 PacBlue, CD31 PacBlue (Biolegend).
Cells were gated on the basis of forward-and side-scatter profiles, and live/dead discrimination was obtained with DAPI. Analyses and sorting was performed using a FACS Aria II (BD Biosciences). In vitro mammary colony-forming assays. 96-well ultra-low attachment plates (BD Biosciences) were prepared with a feeder layer of irradiated L-WNT3a mixed with 60 ml of growth factor reduced Matrigel (BD) per well. 1000 sorted MRUs from WT, Ts65Dn or Ts1Cje mice were then plated into liquid media as previously described 33, 34 . 10% FBS and 2.5% growth factor reduced Matrigel were added as supplements.
2 ) cell populations were isolated from 12-week-old mice in staining media and re-suspended in 10 ml of sterile PBS 1 30% Matrigel per transplant before being injected into the cleared fat pads of 21-28-day-old recipient NOD/SCID mice as described previously 21 . All transplants were allowed to grow for at least 6 weeks but not more than 10 weeks before analysis. For knockdown of Ups16, Lin 2 cells were infected with either control lentivirus or shRNA against Usp16 in DMEM/F12 plus 10% FBS overnight. The cells were then washed and re-suspended in sterile PBS plus 30% Matrigel for transplant.
For mammary transplant outgrowth area calculation, NIH Image J software was used. In brief, GFP-positive mammary ducts were measured with the freehand tool by drawing a shape around the duct. Measurements were performed in a 'blind' fashion and at the same magnification for all samples. The entire fat pad was used to determine the maximum area coverage (100%). Only positive outgrowths were used in the measurement. Immunofluorescence of mammary tissue. 12-week-old mice were euthanized and mammary glands were surgically removed. Glands were fixed in formalin overnight and then transferred to 70% ethanol. They were then embedded in paraffin and sectioned for histology. For staining the slides were de-parafinized in xylene and alcohol grades. Antigen retrieval was carried out in Tris-EDTA buffer by heating in a microwave for 20 min. Primary antibodies CK14 AF64 (Covance) and CK8 (Developmental Studies Hybridoma Bank, University of Iowa) were applied overnight. Secondary antibodies were anti-rat DyLight 488 and anti-rabbit DyLight 594 (both from Jackson Laboratories). Sections were then mounted using ProLong Antifade reagent (Invitrogen). Images were taken with a NIKON inverted ARTICLE RESEARCH microscope. Lumosity software was used to quantify the Pearson's correlation of overlapping between CK8 and CK14. Western blot and ChIP. For western blot analyses, chromatin extracts were prepared with subcellular protein fractionation kit (Thermo Scientific). H2AK119 antibody (rabbit) was purchased from Cell Signaling; H2A antibody was purchased from Millipore.
ChIP was performed essentially as described previously 35 using the polyclonal antibody for H2AK119 (Cell Signaling). Lentivirus preparation. The lentiviral vector that we used for downregulation was vector pSicoR-GFP 36 . We cloned the following hairpins: shC (59-TTCTCCG AACGTGTCACGT-39) shUsp16 no. 1 (59-CGAGTGCTGTATTCCTTATAT-39), shUsp16 no. 2 (59-TTCTCTGGAAATACACCTATG-39), shp16 (59-CATCAAGA CATCGTGCGATAT-39), shp19 (59-GCCATCTAAACGGTTCAGTTT-39), human shUSP16 (59-TATATCAGTTCACCCGTAAT-39). A lentivirus construct expressing mCherry and Bmi1 (pEIZ-HIV-mCherry-Bmi1) was kindly provided by Y. Shimono 37 . USP16 overexpression vector was obtained by subcloning USP16 clone (ATCC) in pCDH-MSCV-GFP vector or pCDH-EF1A-GFP vector (System Biosciences).
Viruses were produced in 293T cells with a second-generation lentivirus system. Supernatants were collected at 48 h and 72 h, and concentrated through ultracentrifugation 38 . Viral titres were calculated by FACS analyses of 293T cells infected with serial dilution of concentrated virus. MEFs, TTFs and human fibroblasts. MEFs were generated from E14.5 embryos obtained from Ts65Dn mothers. Genotype was verified by real-time PCR. Cells were passaged 1:4 when almost confluent. To culture mouse primary TTFs, the skin was peeled from tail tips of wild-type (n 5 4), Ts65Dn (n 5 3), Ts65Dn/Usp16 het (n 5 3) and Usp16 het (n 5 1) 8-week-old mice, finely minced with a blade and shortly digested in trypsin. Resulting pieces were incubated in DMEM containing 20% FBS for 3 weeks. Derived fibroblasts were then passaged to new plates and considered P2. Human fibroblasts (wild type: CRL-2088, CRL-2076; Down's syndrome: CCL-54, CRL-7090, CRL-7031) were purchased by ATCC. Other fibroblast cultures (Down's syndrome: GM2508 and normal fibroblasts) were kindly provided by J. Weimann and S. Marro (Stanford University). Fibroblast proliferation, SA-bgal and p16 staining. In total, 5 3 10 3 fibroblasts were seeded in a 24-well plate and viable cells were counted by trypan blue exclusion at the indicated time points.
For SA-bgal staining of senescent cells, the Senescence Detection Kit (Abcam, ab65351) was used according to manufacturer's protocol.
For p16 staining, fibroblasts were permeabilized with 0.2% Triton-PBS, blocked in 3% BSA-PBS and stained with a mouse anti-human p16 (JC8, Santa Cruz Biotechnology) or rabbit anti-mouse p16. Specific secondary antibodies (Alexa Fluor 488 anti-mouse and Alexa Fluor 647 anti-rabbit, Invitrogen) were used (1:1,000).
SA-ßGal and p16 staining were detected by microscope at 310 and the positive cells were evaluated in three different fields per well. Three technical replicates were performed.
In experiments with infected cells, cells were sorted on the basis of GFP or mCherry expression and expression of the construct was verified by real-time PCR. Human neurosphere assays. Human adult SVZ neurospheres were derived from a rapid autopsy excised adult human brain (National Disease Research Interchange) SVZ. Paediatric SVZ neurospheres were derived from subventricular tissue surgically excised during a functional hemispherectomy. Human tissue was acquired under institutional-approved IRB protocol no. 18672 and the Stanford Stem Cell Research Oversight (SCRO) committee no. 370.
Human tissue was digested using collagenase IV (1 mg ml 21 ) and DNase I (250 U ml 21 ) at 37 uC for 30 min followed by trituration using a fire-polished pipette. Digested tissue was washed in ice-cold HBSS without calcium and magnesium, filtered through a 40-mm filter and re-suspended in neurospheres growth media that is, Neurobasal-A (Invitrogen) and DMEM F/12 (1:1) supplemented with 2% B27-A (Invitrogen), 1% N2 (Invitrogen), human recombinant EGF (20 ng ml c, Peripheral blood analyses four months after bone marrow transplant revealed multi-lineage engraftment in Ts65Dn mice with only 500,000 donor cells; lower doses of Ts65Dn donor bone marrow failed to reconstitute haematopoietic lineages. d, Multi-lineage analyses of peripheral blood 3 months after bone marrow transplantation showed that Ts65Dn bone marrow cells failed to reconstitute secondary recipients. Representative FACS plots are shown.
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